Categories: Health

Transactions under Novonesis share buyback program

Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated  1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025.

Please read the full announcement in PDF.

Attachment

GlobeNews Wire

Recent Posts

Hyundai Motor Group Showcases Hydrogen Technologies Across the Value Chain at World Hydrogen Expo in Korea

Hyundai Motor Group, together with its 7 affiliates, highlights cutting-edge hydrogen technologies and real-world applications…

2 hours ago

Spectacular celebrations as the Olympic flame arrives in Italy ahead of the Olympic Winter Games Milano Cortina 2026

05 December 2025 - Celebrations have taken place in Rome to mark the arrival of the…

2 hours ago

14th Olympic Summit on 11 December 2025 Information for the media

05 December 2025 - The International Olympic Committee (IOC) will host the 14th Olympic Summit on…

2 hours ago

CocaCola music festival set to ignite Olympic Torch Relay celebrations in Rome

05 December 2025 - As the Olympic flame prepares to begin its journey through Italy ahead…

2 hours ago

Godrej Industries Group’s Assistive Tech Conference promotes accessible and equitable workplaces in India

MUMBAI, India, Dec. 6, 2025 /PRNewswire/ -- Godrej Industries Group recently hosted its inaugural Assistive…

3 hours ago

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab…

5 hours ago